Anne Wojcicki is set to regain control of 23andMe after a nonprofit she controls topped Regeneron Pharmaceuticals' bid for ...

Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a ...

House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.

Lawmakers raised questions and concerns about the sale of genetic-testing company 23andMe during a hearing on Tuesday.

The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the ...

PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking ...

An independent privacy official will oversee 23andMe’s proposed sale after Illinois and 26 other states raised concerns about ...

Regeneron is willing to make a new bid for 23andMe's assets, but wants a $10 million breakup fee if Wojcicki’s bid is ...

The bipartisan lawsuit was filed on Monday in St. Louis alongside a separate objection to the bankruptcy sale and is being ...

People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest ...